Baillie Gifford & Co’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.1M | Sell |
|
|||||
|
2025
Q1 | $20.3M | Sell |
|
|||||
|
2024
Q4 | $34.6M | Sell |
|
|||||
|
2024
Q3 | $25.9M | Sell |
|
|||||
|
2024
Q2 | $28.9M | Sell |
|
|||||
|
2024
Q1 | $31.1M | Sell |
|
|||||
|
2023
Q4 | $72.3M | Sell |
|
|||||
|
2023
Q3 | $110M | Sell |
|
|||||
|
2023
Q2 | $361M | Buy |
|
|||||
|
2023
Q1 | $517M | Sell |
|
|||||
|
2022
Q4 | $650M | Sell |
|
|||||
|
2022
Q3 | $677M | Sell |
|
|||||
|
2022
Q2 | $634M | Sell |
|
|||||
|
2022
Q1 | $774M | Sell |
|
|||||
|
2021
Q4 | $722M | Buy |
|
|||||
|
2021
Q3 | $1.09B | Buy |
|
|||||
|
2021
Q2 | $2.06B | Buy |
|
|||||
|
2021
Q1 | $1.17B | Buy |
|
|||||
|
2020
Q4 | $1.43B | Buy |
|
|||||
|
2020
Q3 | $904M | Buy |
|
|||||
|
2020
Q2 | $469M | Buy |
|
|||||
|
2020
Q1 | $521M | Sell |
|
|||||
|
2019
Q4 | $675M | Sell |
|
|||||
|
2019
Q3 | $647M | Sell |
|
|||||
|
2019
Q2 | $558M | Buy |
|
|||||
|
2019
Q1 | $387M | Buy |
|
|||||
|
2018
Q4 | $151M | Buy |
|
|||||
|
2018
Q3 | $185M | Buy |
|
|||||
|
2018
Q2 | $96.8M | Buy |
|
|||||
|
2018
Q1 | $59.9M | Buy |
|
|||||
|
2017
Q4 | $12.2M | Buy |
|